Hangzhou Kang Ming Information Technology Co., Ltd, (HKG: 9955) trading under the moniker “ClouDr”, has entered into a partnership with CR Sanjiu (SHE: 000999), a state-owned pharmaceutical company specializing in treatments for cardiovascular and cerebrovascular diseases and endocrine disorders.
Under this strategic alliance, ClouDr will serve as the general agent for CR Sanjiu’s cardiovascular medicine, XueSaiTongRuanJiaoNang, within the core sales province hospital channel for a three-year term. ClouDr is set to utilize its robust digital capabilities and comprehensive hospital channel resources to improve patient accessibility and promotional efficiency of the product, and to amplify its brand influence.- Flcube.com
